Vertex Pharmaceuticals Inc (VRTX)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 16,409,600 | 17,580,400 | 13,912,700 | 10,100,000 | 8,686,800 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $16,409,600K
= 0.00
The debt-to-equity ratio for Vertex Pharmaceuticals Inc has consistently remained at 0.00 for the years 2020, 2021, 2022, 2023, and 2024. This indicates that the company has no debt on its balance sheet relative to its equity during these years. A debt-to-equity ratio of 0.00 reflects a very low financial risk for the company and suggests that it has been financing its operations primarily through equity rather than debt. Overall, Vertex Pharmaceuticals seems to have a conservative financial structure and is not highly leveraged, which can be a positive indicator of financial stability and strength.
Peer comparison
Dec 31, 2024